Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension

Despite the increase in therapeutic options, parenteral prostacyclins remain the cornerstone in the medical management of pulmonary arterial hypertension (PAH). While the use of parenteral prostacyclins in pediatric patients is well documented, less is known about alternative drug delivery methods s...

Descripción completa

Detalles Bibliográficos
Autores principales: Colglazier, Elizabeth, Stevens, Leah, Parker, Claire, Nawaytou, Hythem M., Amin, Elena K., Becerra, Jasmine, Steurer, Martina, Fineman, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732384/
https://www.ncbi.nlm.nih.gov/pubmed/36514390
http://dx.doi.org/10.1002/pul2.12159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732384/
https://www.ncbi.nlm.nih.gov/pubmed/36514390
http://dx.doi.org/10.1002/pul2.12159

Ejemplares similares